Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline in Diabetic Kidney Disease
NCT03625648Phase 4Active, not recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2019
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diabetic kidney disease (DKD) comparing PTX with Placebo (2 arms). Primary endpoint: Time to End-Stage Renal Disease or Death. Started Nov 2019; status: active, not recruiting.
02
Drugs
pentoxifylline
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT03625648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03625648.